Amneal Pharmaceuticals, Inc. AMRX India — Long-Lived Assets
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The official record: Amneal Pharmaceuticals, Inc.’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s india — long-lived assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s india — long-lived assets?
- Amneal Pharmaceuticals, Inc. (AMRX) reported india — long-lived assets of $176.67M in Q4 2025.
- How has Amneal Pharmaceuticals, Inc.'s india — long-lived assets changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s india — long-lived assets increased by 10.7% year-over-year, from $159.65M to $176.67M.
- What does india — long-lived assets mean?
- This metric represents the total book value of non-current, tangible, and intangible assets physically located or legally domiciled within the India geographic segment. It reflects the company's investment in manufacturing facilities, research infrastructure, and operational capacity within this region. Monitoring this balance helps investors assess the scale of the company's regional footprint and the capital intensity required to support its international supply chain and production capabilities.